3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
CNS
1
Conditions
Brain Neoplasms
635
Glioblastoma
566
Glioma
405
Neuroblastoma
174
Neoplasms
123
Astrocytoma
106
Central Nervous System Neoplasms
103
Medulloblastoma
87
Breast Neoplasms
86
Meningioma
82
Carcinoma, Non-Small-Cell Lung
78
Melanoma
77
Lung Neoplasms
69
Sarcoma
66
Ependymoma
64
Neurofibromatosis 1
63
Recurrence
50
Oligodendroglioma
48
Neoplasm Metastasis
48
Osteosarcoma
47
Meningeal Carcinomatosis
46
Rhabdomyosarcoma
45
Diffuse Intrinsic Pontine Glioma
44
Pheochromocytoma
43
Rhabdoid Tumor
41
Paraganglioma
41
Gliosarcoma
40
Sarcoma, Ewing
39
Pancreatic Neoplasms
39
Colorectal Neoplasms
33
Interventions
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NF1
×
CNS
×
1 year
×
Clear all
NCT06159166
2026-04-13
Mirda
Johns Hopkins University
Phase 1/2
Recruiting
24 enrolled